Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1009 of 1,261
  1. US 7674935

    Crystal forms of O-desmethylvenlafaxine

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted
  2. US 7674923

    Process for preparing forms of atorvastatin calcium substantially free of impurities

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted
  3. US 7674908

    Indazole-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted
  4. US 7674779

    RNAi modulation of MLL-AF4 and uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted
  5. US 7674787

    Conformationally constrained Smac mimetics and the uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted
  6. US 7674249

    Gels with predetermined conductivity used in electroporation of tissue

    The Regents of the University of California · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted
  7. US 7674777

    Immunostimulatory nucleic acid molecules

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted
  8. US 7674778

    Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine

    Alnylam Pharmaceuticals, Inc. · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted
  9. US 7674879

    Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof

    Nektar Therapeutics · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted
  10. US 7674480

    Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted
  11. US 7671058

    N-(3,4-disubstituted phenyl) salicylamide derivatives

    Institute of Medicinal Molecular Design, Inc. · Granted Mar 2, 2010 · Expires Feb 25, 2030

    granted
  12. US 7670855

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

    The Regents of the University of California · Granted Mar 2, 2010 · Expires Feb 25, 2030

    granted
  13. US 7671071

    Polymorphic Form XVI of fexofenadine hydrochloride

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 2, 2010 · Expires Feb 25, 2030

    granted
  14. US 7670599

    YKL-40 as a marker and prognostic indicator for cancers

    The Regents of the University of California · Granted Mar 2, 2010 · Expires Feb 25, 2030

    granted
  15. US 7670600

    Molecules with extended half-lives, compositions and uses thereof

    The Board of Regents of the University of Texas System · Granted Mar 2, 2010 · Expires Feb 25, 2030

    granted
  16. US 7670767

    Genetic alterations associated with cancer

    The Board of Regents of the University of Texas System · Granted Mar 2, 2010 · Expires Feb 25, 2030

    granted
  17. US 7670806

    ADP-ribosyl acceptor hydrolase 3 (ARH3) polypeptides and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 2, 2010 · Expires Feb 25, 2030

    granted
  18. US 7671174

    Ligand to GPR8

    Takeda Pharmaceutical Company Limited · Granted Mar 2, 2010 · Expires Feb 25, 2030

    granted
  19. US 7671221

    Modulators of ATP-Binding Cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Mar 2, 2010 · Expires Feb 25, 2030

    granted
  20. US 7671198

    Process for preparing intermediates to 5-HT4 receptor agonist compounds

    Theravance, Inc. · Granted Mar 2, 2010 · Expires Feb 25, 2030

    granted
  21. US 7666619

    Compounds and methods for regulating bacterial growth and pathogenesis

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Feb 23, 2010 · Expires Feb 18, 2030

    granted
  22. US 7666674

    Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 23, 2010 · Expires Feb 18, 2030

    granted
  23. US 7666647

    Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

    Vertex Pharmaceuticals Incorporated · Granted Feb 23, 2010 · Expires Feb 18, 2030

    granted
  24. US 7666846

    Cholesterol-containing compounds and their use as immunogens against Borrelia burgdorferi

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 23, 2010 · Expires Feb 18, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.